TAVR continues to gain momentum as a go-to treatment option. A group of experts convened at CRT 2026 to discuss where the field stands today and what questions remain unanswered. TAVR continues to gain momentum as a go-to treatment option. A group of experts convened at CRT 2026 to discuss where the field stands today and what questions remain unanswered. | | |
|
Six in 10 cardiovascular imagers report feelings of burnout, and many of them are thinking about leaving the field altogether. Six in 10 cardiovascular imagers report feelings of burnout, and many of them are thinking about leaving the field altogether. | | |
|
The FDA has authorized four new flavored nicotine pouches, highlighting their potential to help adults stop smoking cigarettes. The American Heart Association shared its concerns with the move, saying "key questions" remain unanswered. The FDA has authorized four new flavored nicotine pouches, highlighting their potential to help adults stop smoking cigarettes. The American Heart Association shared its concerns with the move, saying "key questions" remain unanswered. | | |
|
The Affera Mapping and Ablation System with Sphere-9 Catheter can now be used to treat more patients in Europe. Medtronic also received good news from the FDA about the all-in-one device. The Affera Mapping and Ablation System with Sphere-9 Catheter can now be used to treat more patients in Europe. Medtronic also received good news from the FDA about the all-in-one device. | | |
|
|
Access to cardiac PET remains limited, but working together with radiology departments is one way to overcome the significant capital investment. Access to cardiac PET remains limited, but working together with radiology departments is one way to overcome the significant capital investment. | | |
|
Vexev, an Australian medtech company, wants to improve patient access to high-quality vascular imaging. The company has now raised a total of $19 million. Vexev, an Australian medtech company, wants to improve patient access to high-quality vascular imaging. The company has now raised a total of $19 million. | | |
|
The American College of Cardiology has shared an updated guidance that highlights the importance of vaccination for patients with a history of CVD. The American College of Cardiology has shared an updated guidance that highlights the importance of vaccination for patients with a history of CVD. | | |
|
The ZEUS trial fell short, but Novo Nordisk still has high hopes for HERMES and ARTEMIS. The ZEUS trial fell short, but Novo Nordisk still has high hopes for HERMES and ARTEMIS. | | |
|
|
Back in June, CMS proposed significant updates to its current TAVR policies. Three leading healthcare societies have now joined forces to share their own perspective on the potential updates. Back in June, CMS proposed significant updates to its current TAVR policies. Three leading healthcare societies have now joined forces to share their own perspective on the potential updates. | | |
|
In addition to launching Heartflow Plaque Staging, the company also shared new data at SCCT2026 highlighting the importance of using total plaque volume assessments to diagnose and manage heart patients. In addition to launching Heartflow Plaque Staging, the company also shared new data at SCCT2026 highlighting the importance of using total plaque volume assessments to diagnose and manage heart patients. | | |
|
Drinking multiple cups of coffee each day may decrease a person's risk of heart disease, heart failure and stroke. However, too much caffeine can still cause issues. Drinking multiple cups of coffee each day may decrease a person's risk of heart disease, heart failure and stroke. However, too much caffeine can still cause issues. | | |
|
|
She quit her post in disgust last August after serving a decade in the C-suite of the Centers for Disease Control and Prevention. Now Deb Houry, MD, MPH, is looking out over U.S. healthcare with glass-half-full enthusiasm. She quit her post in disgust last August after serving a decade in the C-suite of the Centers for Disease Control and Prevention. Now Deb Houry, MD, MPH, is looking out over U.S. healthcare with glass-half-full enthusiasm. | | |
|
New survey data reveal a concerning trend of discriminatory behavior against minority radiographers in the United Kingdom. New survey data reveal a concerning trend of discriminatory behavior against minority radiographers in the United Kingdom. | | |
|
![A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]](https://cardiovascularbusiness.com/sites/default/files/styles/media_thumbnail/public/2024-09/istock-1209664264.jpg?itok=d9hdApI9)
